Contact Us Site Map Directions Join our Mailing List
 
Washington Technology Center Funding & Services Microfabrication Lab Industries Initiative News Forum
Northstar Neuroscience

Seattle

 
About Northstar Neuroscience, Inc.
Northstar Neuroscience (NASDAQ:NSTR) is a medical device company focused on developing neuromodulation therapies to treat neurological injury, disorder and disease.  Northstar’s proprietary Renova™ Cortical Stimulation System* is an investigational device that delivers targeted electrical stimulation to the outer surface of the brain – the cerebral cortex.  The Renova system is currently under investigation for several indications. For more information, visit www.northstarneuro.com.
 
*CAUTION: Investigational Device. Limited by Federal Law (U.S.) to investigational use.
 
 
Research & Technology Development (RTD) Award: Phase I (* project canceled)
 
Project Title: “Implantable recurrent brain-computer interface for activity-dependent brain stimulation”
 
Research Partner: Eberhard Fetz, Ph.D., Professor, Department of Physiology & Biophysics, University of Washington
 
Project Began: 2008
 
In partnership with Northstar Neuroscience, the UW Department of Physiology & Biophysics plans to further research and develop cortical stimulation as a form of therapy for stroke survivors. Cortical stimulation refers to the process of stimulating the cerebral cortex, or the outermost layer of the brain with low levels of electricity to promote neuroplasticity, which may lead to an improvement of motor function.
 
 UW will receive $79,992 in Phase I Research and Technology Development funding from Washington Technology Center and $16,000 from Northstar Neuroscience for the project titled “Implantable recurrent brain-computer interface for activity-dependent brain stimulation.” In this Phase I project, UW Professor Eberhard Fetz and Northstar Neuroscience will leverage the resources of the University of Washington and Washington Technology Center to develop technology that will use neural and muscular activity to control electrical brain stimulation during stroke rehabilitation. The technology may ultimately be integrated with Northstar’s Renova™ Cortical Stimulation System with the goal of improving the lives of stroke patients.
 
Each year, more than 700,000 people in the U.S. suffer a stroke. Physical therapy is the most frequently prescribed post-acute treatment for stroke survivors; however, this therapy is often offered for only a brief time post-stroke and is rarely continued long-term due to the misconception that brain function is beyond repair a certain period after the initial stroke. Recent studies have shown that repetitive, targeted cortical stimulation of the brain during physical therapy may increase recovery of speech and motor function in stroke patients.
"With the ground-breaking research taking place in Seattle, this grant helps ensure that Washington state will remain at the forefront of the biotechnology industry."
 
State Sen. Jeanne Kohl-Welles (D-Seattle).
"The partnership between the University of Washington and Northstar Neuroscience Inc. holds great promise for jobs and even more importantly for stroke victims. This is exactly the kind of collaboration that can keep Seattle at the forefront of high tech job creation."
 
 State Rep. Mary Lou Dickerson (D-Seattle)